Integrow Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 15989.73%
- Profit Growth 15736.00%
- Ebitda 100052.00%
- Net Worth 304.97%
- Total Assets 1478.49%
About Integrow Life Sciences
Integrow Life Sciences Private Limited (ILSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2015 (Nine years and seven months 17 days old ). Its registered office is in East Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmendra Singh and Ashish Pandey serve as directors at the Company.
Company Details
- Location
East Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52311DL2015PTC282605
- Company No.
282605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2015
- Date of AGM
19 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Integrow Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Pandey  | Director | 14-Feb-2022 | Current |
| Dharmendra Singh | Director | 15-Mar-2019 | Current |
Financial Performance of Integrow Life Sciences.
Integrow Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15989.73% increase. The company also saw a substantial improvement in profitability, with a 15736% increase in profit. The company's net worth Soared by an impressive increase of 304.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integrow Life Sciences?
Unlock access to Integrow Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dmp Healthcare Private LimitedDharmendra Singh and Ashish Pandey are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Integrow Life Sciences?
Unlock and access historical data on people associated with Integrow Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrow Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrow Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
